理学療法ジャーナル56巻6号

2022年06月発行

特集 医療現場におけるサルコペニア・フレイル

循環器疾患領域におけるサルコペニア・フレイル

著者： 片野唆敏¹ 長岡凌平¹ 沼澤瞭¹

所属機関： ¹札幌医科大学附属病院リハビリテーション部

ページ範囲：P.650 - P.656

Point

●サルコペニアやフレイルを合併する心不全では予後が悪い

●サルコペニアはフレイルの中核因子であり，心不全の病態と密接に関連する

●フレイル合併心不全の治療では，心不全の標準治療，運動療法，栄養療法が中心となる

参考文献

1）Goldwater DS, et al：Frailty in advanced heart failure：a consequence of aging or a separate entity? Clin Med Insights Cardiol 2015；9（Suppl 2）：39-46

2）Morley JE, et al：Frailty consensus：a call to action. J Am Med Dir Assoc 2013；14：392-397

3）Fried LP, et al：Frailty in older adults：evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001；56：M146-M157. doi：10.1093/gerona/glv096

4）Satake S, et al：The revised Japanese version of the cardiovascular health study criteria（revised J-CHS criteria）. Geriatr Gerontol Int 2020；20：992-993

5）Kojima G, et al：Prevalence of frailty in Japan：a systematic review and meta-analysis. J Epidemiol 2017；27：347-353

6）Marengoni A, et al：Heart failure, frailty, and pre-frailty：a systematic review and meta-analysis of observational studies. Int J Cardiol 2020；316：161-171

7）Matsue Y, et al：Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure：the FRAGILE-HF cohort study. Eur J Heart Fail 2020；22：2112-2119

8）Uchmanowicz I, et al：Frailty and the risk of all-cause mortality and hospitalization in chronic heart failure：a meta-analysis. Esc Heart Fail 2020；7：3427-3437

9）Chen LK, et al：Asian Working Group for Sarcopenia：2019 Consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 2020；21：300-307.e2. doi：10.1016/j.jamda.2019.12.012

10）Cruz-Jentoft AJ, et al：Sarcopenia：revised European consensus on definition and diagnosis. Age Ageing 2019；48：16-31

11）Katano S, et al：Novel prediction equation for appendicular skeletal muscle mass estimation in patients with heart failure：potential application in daily clinical practice. Eur J Prev Cardiol 2021；28：e18-e21. doi：10.1177/2047487320904236

12）Sanada K, et al：A cross-sectional study of sarcopenia in Japanese men and women：reference values and association with cardiovascular risk factors. Eur J Appl Physiol 2010；110：57-65

13）Makizako H, et al：Prevalence of sarcopenia defined using the Asia Working Group for Sarcopenia criteria in Japanese community-dwelling older adults：a systematic review and meta-analysis. Phys Ther Res 2019；22：53-57

14）Konishi M, et al：Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction. Eur J Prev Cardiol 2021；28：1022-1029

15）Zhang Y, et al：Sarcopenia in heart failure：a systematic review and meta-analysis. Esc Hear Fail 2021；8：1007-1017

16）Fülster S, et al：Muscle wasting in patients with chronic heart failure：results from the studies investigating co-morbidities aggravating heart failure（SICA-HF）. Eur Heart J 2013；34：512-519

17）Konishi M, et al：Prognostic impact of muscle and fat mass in patients with heart failure. J Cachexia Sarcopenia Muscle 2021；12：568-576

18）von Haehling S, et al：Muscle wasting as an independent predictor of survival in patients with chronic heart failure. J Cachexia Sarcopenia Muscle 2020；11：1242-1249

19）von Haehling S von, et al：Muscle wasting and cachexia in heart failure：mechanisms and therapies. Nat Rev Cardiol 2017；14：323-341

20）Lena A, et al：Muscle wasting and sarcopenia in heart failure—the current state of science. Int J Mol Sci 2020；21：6549. doi：10.3390/ijms21186549

21）Pasini E, et al：Inadequate nutritional intake for daily life activity of clinically stable patients with chronic heart failure. Am J Cardiol 2004；93：41A-43A

22）Aquilani R, et al：Is nutritional intake adequate in chronic heart failure patients? J Am Coll Cardiol 2003；42：1218-1223

23）Clark AL, et al：Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure：results from the COPERNICUS trial. J Cachexia Sarcopenia Muscle 2017；8：549-556

24）Anker SD, et al：Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors：an observational study. Lancet 2003；361：1077-1083

25）Katano S, et al：Does renin-angiotensin system inhibition have impacts on muscle mass and bone mineral density in heart failure patients? ESC Heart Fail 2021；8：2617-2624

26）Dereli S, et al：Effects of sacubutril/valsartan on nutritional status in heart failure with reduced ejection fraction. J Cardiovasc Med（Hagerstown）2020；21：13-20

27）Kitzman DW, et al：Physical rehabilitation for older patients hospitalized for heart failure. N Engl J Med 2021；385：203-216

28）Kamiya K, et al：Multidisciplinary cardiac rehabilitation and long-term prognosis in patients with heart failure. Circ Heart Fail 2020；13：e006798. doi：10.1161/CIRCHEARTFAILURE.119.006798

29）Carbone S, et al：Lean mass abnormalities in heart failure：the role of sarcopenia, sarcopenic obesity, and cachexia. Curr Probl Cardiol 2020；45：100417. doi：10.1016/j.cpcardiol.2019.03.006

30）Senden PJ, et al：The effect of physical training on workload, upper leg muscle function and muscle areas in patients with chronic heart failure. Int J Cardiol 2005；100：293-300

31）Katano S, et al：Nutritional status and energy intake as predictors of functional status after cardiac rehabilitation in elderly inpatients with heart failure—a retrospective cohort study. Circ J 2018；82：1584-1591

32）Katano S, et al：Energy intake during hospital stay predicts all-cause mortality after discharge independently of nutritional status in elderly heart failure patients. Clin Res Cardiol 2021；110：1202-1220

33）Aquilani R, et al：Oral amino acid supplements improve exercise capacities in elderly patients with chronic heart failure. Am J Cardiol 2008；101：104E-110E. doi：10.1016/j.amjcard.2008.03.008

34）Rozentryt P, et al：The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers：a randomized, double-blind pilot study. J Cachexia Sarcopenia Muscle 2010；1：35-42

35）サルコペニア診療ガイドライン作成委員会：サルコペニア診療ガイドライン（2017年版 一部改訂）．2020. https://minds.jcqhc.or.jp/docs/gl_pdf/G0001021/4/sarcopenia2017_revised.pdf（2022年1月閲覧）

36）Bauer J, et al：Sarcopenia：a time for action. An SCWD Position Paper. J Cachexia, Sarcopenia and Muscle 2019；10：956-961

37）Deutz NEP, et al：Protein intake and exercise for optimal muscle function with aging：recommendations from the ESPEN Expert Group. Clin Nutr 2014；33：929-936

38）Jung H-W, et al：Protein intake recommendation for Korean older adults to prevent sarcopenia：expert consensus by the Korean Geriatric Society and the Korean Nutrition Society. Ann Geriatr Med Res 2018；22：167-175

39）日本循環器学会，他：2021年改訂版 心血管疾患におけるリハビリテーションに関するガイドライン．2021. https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Makita.pdf（2022年1月閲覧）

40）Hersberger L, et al：Individualized nutritional support for hospitalized patients with chronic heart failure. J Am Coll Cardiol 2021；77：2307-2319